Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Microbot Medical ( (MBOT) ) has provided an update.
Between August 26 and August 27, 2025, Microbot Medical Inc. issued 4,055,870 shares of its common stock following the exercise of Series H and Series I preferred investment options. This transaction generated approximately $8.6 million in gross proceeds for the company, enhancing its financial position and potentially impacting its market operations.
The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. operates in the medical technology industry, focusing on developing innovative robotic systems for minimally invasive surgeries and procedures.
Average Trading Volume: 2,186,562
Technical Sentiment Signal: Buy
Current Market Cap: $176.7M
For a thorough assessment of MBOT stock, go to TipRanks’ Stock Analysis page.